Vaping for weight control: A cross-sectional population study in England.


Journal

Addictive behaviors
ISSN: 1873-6327
Titre abrégé: Addict Behav
Pays: England
ID NLM: 7603486

Informations de publication

Date de publication:
08 2019
Historique:
received: 15 01 2019
revised: 19 03 2019
accepted: 05 04 2019
pubmed: 14 4 2019
medline: 29 9 2020
entrez: 14 4 2019
Statut: ppublish

Résumé

Concern about weight gain is a barrier to smoking cessation. E-cigarettes may help quitters to control their weight through continued exposure to the appetite-suppressant effects of nicotine and behavioural aspects of vaping. This study explored the views and practices of smokers, ex-smokers and current e-cigarette users relating to vaping and weight control. Cross-sectional survey of past-year smokers (n = 1320), current smokers (n = 1240) and current e-cigarette users (n = 394) in England, conducted April-July 2018. Data were weighted to match the English population on key sociodemographic characteristics. Of e-cigarette users, 4.6% (95%CI 2.6-6.6) reported vaping for weight control, and 1.9% (95%CI 0.6-3.2) reported vaping to replace meals/snacks. It was rare for individuals who had smoked in the past year to have heard (8.8%, 95%CI 7.3-10.3) or believe (6.4%, 95%CI 5.1-7.7) that vaping could help control weight. Women (OR = 0.62, 95%CI 0.42-0.93) and older people (OR = 0.30, 95%CI 0.13-0.72) were less likely to have heard the claim and women were less likely to believe it (OR = 0.44, 95%CI 0.27-0.72). However, 13.4% (95%CI 11.3-15.5) and 13.1% (95%CI 11.0-15.2) of current smokers who did not use e-cigarettes said they would be more likely to try e-cigarettes or quit smoking, respectively, if vaping could help control their weight. One in 16 English people who have smoked in the last year believe that vaping would prevent weight gain after stopping. One in 22 people who vape are using e-cigarettes for this purpose. However, should evidence emerge that e-cigarettes prevent weight gain, one in eight people who smoke would be tempted to quit smoking and use e-cigarettes.

Identifiants

pubmed: 30981033
pii: S0306-4603(19)30067-X
doi: 10.1016/j.addbeh.2019.04.007
pmc: PMC6555398
pii:
doi:

Substances chimiques

Appetite Depressants 0
Nicotinic Agonists 0
Nicotine 6M3C89ZY6R

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

211-219

Subventions

Organisme : Cancer Research UK
ID : A22962
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C1417/A22962
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C22086/A24778
Pays : United Kingdom

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

BMC Public Health. 2011 Jun 18;11:479
pubmed: 21682915
Nicotine Tob Res. 2009 Oct;11(10):1182-8
pubmed: 19640835
Am J Public Health. 1992 Jun;82(6):799-803
pubmed: 1585959
Psychopharmacology (Berl). 1984;84(1):120-3
pubmed: 6436879
BMJ. 2012 Jul 10;345:e4439
pubmed: 22782848
Arch Intern Med. 2001 Feb 26;161(4):546-50
pubmed: 11252113
PLoS One. 2015 Apr 17;10(4):e0123579
pubmed: 25886648
Prev Med. 2002 Jun;34(6):616-24
pubmed: 12052022
J Addict Dis. 2001;20(2):5-14
pubmed: 11318397
Addict Behav. 2014 Jun;39(6):1120-5
pubmed: 24679611
Nicotine Tob Res. 2017 Nov 07;19(12):1536-1540
pubmed: 27798086
Public Health Nutr. 1999 Mar;2(1A):125-33
pubmed: 10933632
Am J Public Health. 1994 Nov;84(11):1818-20
pubmed: 7977924
Addiction. 2016 Jun;111(6):1118-9
pubmed: 26920514
Epidemiol Rev. 2007;29:29-48
pubmed: 17478442
J Epidemiol Community Health. 2001 Mar;55(3):185-90
pubmed: 11160173
Tob Control. 2015 Sep;24(5):442-8
pubmed: 24935441
Lancet. 2011 Aug 27;378(9793):815-25
pubmed: 21872750
Front Psychol. 2014 Jul 29;5:781
pubmed: 25120503
Int J Epidemiol. 2015 Apr;44(2):540-50
pubmed: 25777141
Health Technol Assess. 2017 Jun;21(36):1-158
pubmed: 28661375
Psychopharmacology (Berl). 2001 Jan 1;153(2):225-30
pubmed: 11205423
Addiction. 2016 Jan;111(1):3-4
pubmed: 26487081
Cochrane Database Syst Rev. 2012 Jan 18;1:CD006219
pubmed: 22258966
Int J Obes (Lond). 2011 Aug;35(8):1063-70
pubmed: 21042327
J Neurobiol. 2002 Dec;53(4):618-32
pubmed: 12436425
Addiction. 2011 Jan;106(1):188-96
pubmed: 20925685
J Adv Nurs. 2015 Jun;71(6):1210-26
pubmed: 25430626
Addict Behav. 1998 Sep-Oct;23(5):609-22
pubmed: 9768298
Addict Behav. 2017 Mar;66:55-59
pubmed: 27875790
Int J Environ Res Public Health. 2017 Oct 11;14(10):
pubmed: 29019917
Health Psychol. 1993 Jan;12(1):24-32
pubmed: 8462495
Int J Environ Res Public Health. 2018 May 28;15(6):
pubmed: 29843377

Auteurs

Sarah E Jackson (SE)

Department of Behavioural Science and Health, University College London, UK. Electronic address: s.e.jackson@ucl.ac.uk.

Jamie Brown (J)

Department of Behavioural Science and Health, University College London, UK; Department of Clinical, Educational and Health Psychology, University College London, UK.

Paul Aveyard (P)

Nuffield Department of Primary Care Health Sciences, University of Oxford, UK.

Fiona Dobbie (F)

Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, UK.

Isabelle Uny (I)

Institute for Social Marketing, University of Stirling, UK.

Robert West (R)

Department of Behavioural Science and Health, University College London, UK.

Linda Bauld (L)

Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH